- 期刊
The Treatment of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy
並列摘要
Overactive bladder syndrome (OAB) is a common and bothersome problem which affects about 17% of the population in western countries. The treatment of OAB IS usually a challenge due to the high incidence of treatment failure and symptom recurrence. This article reviews various treatments of OAB refractory to antimuscarinic therapy. A literature search for reports on the clinical management of refractory OAB and its efficacy and safety was performed and a total of 55 articles were reviewed. Treatments included intravesical installation of vanilloid agents, intravesical botulinum toxin-A (BoNT-A) injections, neuromodulation and surgery (various types of augmentation enterocystoplasty).
延伸閱讀
- Liaw, Y. M., & Kuo, H. C. (2007). Recent Advances in the Treatment of Overactive Bladder. 臺灣泌尿科醫學會雜誌, 18(2), 61-69. https://www.airitilibrary.com/Article/Detail?DocID=10163220-200706-18-2-61-69-a
- Athanasopoulos, A., & Giannitsas, K. (2011). An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder. Advances in Urology, 2011(), 263-270. https://doi.org/10.1155/2011/820816
- Yeh, C. H., & Chiang, H. S. (2009). Antimuscarinic Therapy-How Long Should We Treat Overactive Bladder?. Incontinence & Pelvic Floor Dysfunction, 3(1S), 24-25. https://doi.org/10.6259/IPFD.2009.3.1S.24
- Kuo, H. C. (2010). Intravesical Treatment for Overactive Bladder Refractory to Antimuscarinics. Incontinence & Pelvic Floor Dysfunction, 4(1), 5-9. https://doi.org/10.6259/IPFD.2010.4.1.5
- Wang, C. C., Chen, J. J., Huang, C. H., & Wang, C. L. (2009). Novel Treatment of Overactive Bladder Refractory to Antimuscarinic Therapy. Incontinence & Pelvic Floor Dysfunction, 3(1S), 26-28. https://doi.org/10.6259/IPFD.2009.3.1S.26